c-myc gene expression in a leukemic T-cell line bearing a t(8;14) (q24;q11) translocation.
We have examined the expression of the c-myc protooncogene in human T-cell leukemic KE-37R cells carrying a t(8;14) (q24;q11) translocation. The breakpoint on chromosome 8 is located at 2.2 kb downstream of c-myc exon 3 and the 3' part of the TcR-alpha gene (14q11) has been juxtaposed to c-myc. Our results showed that the steady-state levels of c-myc RNA transcripts were increased and the P1/P2 ratio of c-myc promoter utilization did not change, indicating that preferential utilization of P2 was maintained in the rearranged gene. High levels of electrophoretically normal p64 and 67 c-myc proteins were detected and both products kept their instability. In addition, transcription from promoter P0 was not detectable. Our results suggest that the activation of the gene is likely to result from its juxtaposition to the enhancer element of the TcR-alpha gene located downstream of the Ca region which stimulates constitutive synthesis of normal c-myc transcripts from the rearranged allele.
Soudon
J
J
Unité 301 INSERM and CNRS SDI No 15954-I, Institut de Génétique Moléculaire, Paris, France.
Bernard
O
O
Mathieu-Mahul
D
D
Larsen
C J
CJ
D015152:Blotting, Northern; D002883:Chromosomes, Human, Pair 14; D002898:Chromosomes, Human, Pair 8; D004742:Enhancer Elements, Genetic; D015870:Gene Expression; D016259:Genes, myc; D006801:Humans; D015458:Leukemia, T-Cell / Q000235:genetics*; D016271:Proto-Oncogene Proteins c-myc / Q000032:analysis; D012313:RNA / Q000032:analysis; D014178:Translocation, Genetic; D014407:Tumor Cells, Cultured
D016271:Proto-Oncogene Proteins c-myc; D012313:RNA